Bank of New York Mellon’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-13,645
| Closed | -$9K | – | 4386 |
|
|
2020
Q4 | $9K | Hold |
13,645
| – | – | ﹤0.01% | 4206 |
|
|
2020
Q3 | $7K | Hold |
13,645
| – | – | ﹤0.01% | 4108 |
|
|
2020
Q2 | $9K | Hold |
13,645
| – | – | ﹤0.01% | 4072 |
|
|
2020
Q1 | $10K | Hold |
13,645
| – | – | ﹤0.01% | 4084 |
|
|
2019
Q4 | $21K | Hold |
13,645
| – | – | ﹤0.01% | 4158 |
|
|
2019
Q3 | $20K | Hold |
13,645
| – | – | ﹤0.01% | 4183 |
|
|
2019
Q2 | $18K | Sell |
13,645
-112,618
| -89% | -$207K | ﹤0.01% | 4191 |
|
|
2019
Q1 | $330K | Buy |
126,263
+7,200
| +6% | +$16.9K | ﹤0.01% | 3717 |
|
|
2018
Q4 | $196K | Buy |
119,063
+43,877
| +58% | +$123K | ﹤0.01% | 3860 |
|
|
2018
Q3 | $364K | Buy |
75,186
+56
| +0.1% | +$318 | ﹤0.01% | 3767 |
|
|
2018
Q2 | $469K | Buy |
75,130
+3,155
| +4% | +$23.5K | ﹤0.01% | 3660 |
|
|
2018
Q1 | $598K | Buy |
71,975
+2,074
| +3% | +$19.8K | ﹤0.01% | 3497 |
|
|
2017
Q4 | $714K | Sell |
69,901
-11,716
| -14% | -$112K | ﹤0.01% | 3432 |
|
|
2017
Q3 | $747K | Buy |
81,617
+22,363
| +38% | +$170K | ﹤0.01% | 3384 |
|
|
2017
Q2 | $433K | Sell |
59,254
-587
| -1% | -$4.43K | ﹤0.01% | 3666 |
|
|
2017
Q1 | $431K | Buy |
59,841
+16,191
| +37% | +$100K | ﹤0.01% | 3608 |
|
|
2016
Q4 | $256K | Buy |
43,650
+11,805
| +37% | +$79.9K | ﹤0.01% | 3824 |
|
|
2016
Q3 | $210K | Sell |
31,845
-6,163
| -16% | -$48.8K | ﹤0.01% | 3884 |
|
|
2016
Q2 | $353K | Buy |
38,008
+16,046
| +73% | +$153K | ﹤0.01% | 3681 |
|
|
2016
Q1 | $237K | Buy |
21,962
+5,417
| +33% | +$57.1K | ﹤0.01% | 3731 |
|
|
2015
Q4 | $237K | Buy |
16,545
+4,832
| +41% | +$72.9K | ﹤0.01% | 3816 |
|
|
2015
Q3 | $246K | Buy |
+11,713
| New | +$258K | ﹤0.01% | 3835 |
|
Bank of New York Mellon's NEOS Position: Q1 2021 in Review
Bank of New York Mellon sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 13,645 shares — an estimated $9K sold.
Bank of New York Mellon first reported a position in NEOS in Q3 2015 and held it in 22 quarters. The position peaked at $747K in Q3 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- Bank of New York Mellon reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- Bank of New York Mellon sold 13,645 Neos Therapeutics, Inc shares in Q1 2021, an estimated $9K.
- Bank of New York Mellon first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 22 quarters.
- Bank of New York Mellon's Neos Therapeutics, Inc position peaked at $747K in Q3 2017.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on Bank of New York Mellon's 13F filing for Q1 2021, filed 13 May 2021.